A UK BASED company has raised millions of pounds to accelerate their groundbreaking gene therapy treatments for dementia and ALS.
Thursday, 30 December 2021
Lifeline for dementia and ALS sufferers as UK company develops groundbreaking treatment
A UK BASED company has raised millions of pounds to accelerate their groundbreaking gene therapy treatments for dementia and ALS.
0 comments:
Post a Comment